PPARA and arteriosclerosis disorder: Through the activation of PPAR-α, they cause an increase in gene expression involved in the β-oxidation of fatty acids leading to the reduction of triglyceride-rich lipoproteins in the serum and to the increase of HDL cholesterol, slowing the progression of arteriosclerosis and reducing cardiovascular events (Figure 2) [31].